Clarion to Lead Panel at the 2019 Wharton Health Care Business Conference
Clarion, a leading life sciences strategy and organizational consultancy, will moderate a panel titled, “Financing Life Science Innovation: Identifying Promising Discoveries and Leveraging New Investing Models to Create Value” at the Wharton Health Care Business Conference (WHCBC) on February 1, 2019.
Tom Murtagh, Clarion managing director and founder, will lead the discussion in which a group of experts across the investment continuum highlight how innovative strategies to capture value from the most profound biomedical advances are rapidly evolving.
- Benjamin Dibling – Executive Director of Licensing, Penn Center for Innovation
- David Konciak – Vice President, Business Development & Strategic Program Management, Surface Oncology
- Sara Nayeem, MD – Partner, NEA
- Cary G. Pfeffer, MD – Partner, Third Rock Ventures
The panel will take place from 9:35 AM – 10:25 AM in the Meade Room at the Union League of Philadelphia. Register to attend WHCBC here. For more information on Clarion’s work, please see the “Our Work” section of our website.
Clarion is a life sciences strategy and organizational consultancy that works together with its clients to envision, craft, and enable growth through innovation and leadership. Across therapeutic categories, Clarion collaborates deeply with its clients to tackle their most complex cross-functional business challenges and decisions throughout the product and company lifecycle. From start-up to global multinational companies, Clarion helps assemble and deliver on inspired strategies that require creativity, insight, and collaboration. Clarion builds leaders across the industry.